Mathias Oelke is Chief Science Officer of NexImmune, Inc.. Currently has a direct ownership of 134,023 shares of NEXI, which is worth approximately $40,206. The most recent transaction as insider was on Nov 22, 2022, when has been sold 126,100 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 134K
0% 3M change
0% 12M change
Total Value Held $40,206

MATHIAS OELKE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2022
BUY
Grant, award, or other acquisition
-
126,100 Added 48.48%
134,023 Common Stock
MO

Mathias Oelke

Chief Science Officer
Gaithersburg, MD

Track Institutional and Insider Activities on NEXI

Follow NexImmune, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEXI shares.

Notify only if

Insider Trading

Get notified when an Nex Immune, Inc. insider buys or sells NEXI shares.

Notify only if

News

Receive news related to NexImmune, Inc.

Track Activities on NEXI